Wall Street Analysts Think Novo Nordisk (NVO) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2249062/wall-street-analysts-think-novo-nordisk-nvo-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2249062
Apr 02, 2024 - The average brokerage recommendation (ABR) for Novo Nordisk (NVO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
0
Is Novo Nordisk the Best Healthcare Stock for You?
https://www.fool.com/investing/2024/03/31/is-novo-nordisk-the-best-healthcare-stock-for-you/?source=iedfolrf0000001
Mar 31, 2024 - Novo Nordisk has been a hot buy in recent years, but in the long run, the stock can still go a whole lot higher.
0
Diversifying Into This Key Market Is 1 More Reason to Buy Novo Nordisk Stock
https://www.fool.com/investing/2024/03/31/diversifying-into-this-key-market-is-1-more-reason/?source=iedfolrf0000001
Mar 31, 2024 - The semaglutide maker just announced a strategic acquisition that will be a green flag for its future value.
0
Why Novo Nordisk (NVO) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2247877/why-novo-nordisk-nvo-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2247877
Mar 29, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
0
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
https://www.zacks.com/stock/news/2247400/pharma-stock-roundup-abbv-nvo-s-new-m-as-fda-nod-to-jnj-mrk-pah-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-2247400
Mar 28, 2024 - While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.
0
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
https://www.zacks.com/stock/news/2246931/viking-vktx-up-17-on-encouraging-oral-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246931
Mar 27, 2024 - Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
0
Wall Street Awaits Consumer Confidence Data
https://www.zacks.com/stock/news/2246106/wall-street-awaits-consumer-confidence-data?cid=CS-ZC-FT-economic_highlights-2246106
Mar 26, 2024 - Wall Street Awaits Consumer Confidence Data
0
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
https://www.zacks.com/stock/news/2245039/novo-nordisk-nvo-gets-positive-chmp-opinion-for-insulin-icodec?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245039
Mar 22, 2024 - Novo Nordisk (NVO) receives a positive opinion from the CHMP for once-weekly basal insulin icodec for the treatment of diabetes in adults.
0
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
https://www.fool.com/investing/2024/03/22/with-shares-near-all-time-highs-is-it-a-buy/?source=iedfolrf0000001
Mar 22, 2024 - The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
0
Novo Nordisk's New Weight Loss Drug Could Be Better Than Ozempic and Wegovy
https://www.fool.com/investing/2024/03/21/novo-nordisks-new-weight-loss-drug-could-be-better/?source=iedfolrf0000001
Mar 21, 2024 - Has Novo Nordisk's already red-hot stock become an even better buy?
0